Explore 3 Stock Ideas & Industry Insights Download Free Report

Avenir Wellness Solutions Inc.

Company price
0.0002 USD 0.00(0%)
Last update at 2026-10-26T20:00:00Z
VOLUME
242452
Market Cap
0.02M

Momentum Score

…

Avenir Wellness Solutions, Inc., together with its subsidiary, The Sera Labs, Inc., engages in the development of nutraceutical formulation and delivery technologies in dosage forms for wellness. The company offers its products in the health, wellness, and beauty sectors under the Seratopical, Seratopical Revolution SeraLabs, and Nutri-Strips brand names. It sells its products to direct-to-consumer through online website orders, including opt-in subscribe and save option, as well as online and in-store at national drug, mass retailers, grocery chains, convenience stores, and on Amazon.com. The company was formerly known as CURE Pharmaceutical Holding Corp. and changed its name to Avenir Wellness Solutions, Inc. in January 2023. Avenir Wellness Solutions, Inc. was incorporated in 2014 and is based in Sherman Oaks, California.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.00
Low
0.00
High
52 Week Price Range
0.00
Low
0.04
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Public information on Avenir Wellness Solutions Inc. (AVRW.US), an OTC-listed issuer, is limited and the company's core operations are not clearly described in widely available filings. Because verified disclosure is scarce, long-term growth drivers are unclear and would depend on management's strategy and execution; investors may find the stock of interest only after reviewing filings or credible operational details.
Material risks include scant disclosure and transparency, low trading liquidity, potential lack of revenue or profitability, high financing and dilution risk, and heightened regulatory and operational uncertainty common among pink-sheet issuers.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.00
Dividend Yield
-
Revenue TTM
2.04M
Revenue Per Share
0.03
Gross Profit TTM
1.44M
Debt / Equity
-0.84
ROE
-
Net Debt
8.23M
ROCE
34.23%
Diluted EPS TTM
-0.03

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Income before tax -3.44M -18.50M -13.19M -30.62M -21.37M
Minority interest - - - 0.00M 0.01M
Net income -3.44M -25.51M -13.19M -30.62M -21.36M
Selling general administrative 6.25M 10.17M 18.88M 11.37M 10.12M
Selling and marketing expenses 2.81M - - - -
Gross profit 3.11M 3.34M 4.38M 0.97M 0.39M
Reconciled depreciation 0.18M 1.58M 3.61M 0.94M 0.58M
Ebit -3.38M - -16.87M -13.18M -11.73M
Ebitda -3.20M -16.45M -9.03M -27.21M -16.68M
Depreciation and amortization 0.18M - - - -
Operating income -5.51M -8.39M -16.87M -13.18M -12.04M
Other operating expenses 9.85M - - - -
Interest expense 0.06M 0.47M 0.55M 2.47M 4.11M
Tax provision 0.00M 0.04M 0.00M 0.00M 0.00M
Interest income 0.05M 0.05M 0.06M 0.04M 0.06M
Net interest income -0.01M -0.41M -0.49M -2.44M -4.05M
Income tax expense 0.00M - - - -
Total revenue 4.35M 4.90M 6.55M 2.05M 0.62M
Total operating expenses 8.62M 13.28M 23.42M 15.23M 12.66M
Cost of revenue 1.24M 1.56M 2.17M 1.08M 0.23M
Total other income expense net 2.06M -9.70M 4.17M -15.01M -5.28M
Net income from continuing ops -3.44M -18.54M -13.19M -30.62M -21.37M
Net income applicable to common shares - - -13.19M -30.62M -21.36M
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 2.61M 6.85M 40.57M 46.36M 32.46M
Intangible assets 0.30M 0.32M 22.29M 25.61M 16.10M
Other current assets 0.29M 0.03M 0.12M 0.78M 1.14M
Total liab 12.49M 13.96M 24.46M 25.08M 18.95M
Total stockholder equity -9.89M -7.11M 16.11M 21.28M 13.51M
Other current liab 1.01M 0.86M 4.39M 2.03M 9.62M
Common stock 0.08M - 0.07M 0.06M 0.04M
Capital stock 0.08M 0.07M 0.07M 0.06M 0.04M
Retained earnings -123.40M -119.95M -94.45M -81.25M -50.63M
Other liab - - - 3.29M 7.07M
Good will - 0.00M 13.87M 13.87M 9.18M
Other assets - - 0.28M 0.06M 0.04M
Cash 0.05M 2.94M 0.02M 1.73M 4.10M
Total current liabilities 12.49M 13.91M 24.26M 14.47M 11.84M
Current deferred revenue 0.42M - - - -
Net debt 8.23M 6.95M 13.58M 14.18M -
Short term debt 8.28M - - - -
Short long term debt 8.24M 9.89M 13.59M 8.89M 0.73M
Short long term debt total 8.28M - - - -
Other stockholder equity 113.44M - 0.34M 0.67M 1.07M
Property plant equipment - - 2.14M 2.47M 0.70M
Total current assets 1.96M 5.93M 1.78M 3.85M 6.19M
Long term investments 0.26M 0.41M 0.22M 0.51M 0.26M
Net tangible assets - - -20.04M -18.19M -11.77M
Net receivables 1.42M 0.23M 0.36M 0.22M 0.14M
Long term debt - - - 7.01M -
Inventory 0.20M 0.14M 0.96M 0.66M 0.16M
Accounts payable 2.45M 1.06M 2.85M 2.13M 1.26M
Non currrent assets other 0.04M 0.04M 0.08M 0.06M 0.04M
Non current assets total 0.65M 0.93M 38.79M 42.51M 26.27M
Capital lease obligations 0.04M 0.17M 0.32M 0.42M 0.06M
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Investments 0.97M 13.84M -0.06M -0.25M -0.26M
Change to liabilities - - 0.26M -0.93M 0.30M
Total cashflows from investing activities 0.97M - -0.17M -1.49M -0.92M
Net borrowings -0.02M - 2.78M 6.06M 1.57M
Total cash from financing activities -0.02M -0.84M 2.78M 8.84M 12.61M
Change to operating activities - - 3.63M 0.73M -1.82M
Net income -3.44M -25.51M -13.19M -30.62M -21.36M
Change in cash -2.89M 2.93M -1.71M -2.37M 3.60M
Begin period cash flow 2.94M 0.02M 1.73M 4.10M 0.50M
End period cash flow 0.05M 2.94M 0.02M 1.73M 4.10M
Total cash from operating activities -3.84M -10.07M -4.32M -9.72M -8.10M
Issuance of capital stock - - - 0.00M 2.50M
Depreciation 0.18M 1.58M 3.61M 0.92M 0.58M
Other cashflows from investing activities 0.97M - - -0.55M -0.20M
Change to inventory 0.02M 0.31M -0.24M -0.15M -0.12M
Change to account receivables -0.21M 0.16M -0.17M -0.06M -0.03M
Other cashflows from financing activities -0.16M - - - -
Change to netincome - - 1.79M 18.89M 13.10M
Capital expenditures 0.05M 0.00M 0.04M 0.67M 0.41M
Change in working capital 1.28M 1.72M 3.48M -0.43M -1.67M
Stock based compensation 0.62M 1.63M 3.88M 3.42M 4.14M
Other non cash items -2.48M -0.70M -1.38M 16.60M 6.88M
Free cash flow -3.90M -10.07M -4.43M -10.41M -8.56M

Peer Comparison*

Sector: Consumer Defensive Industry: Packaged Foods

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
AVRW
Avenir Wellness Solutions Inc.
-
-%
0.00 - - 0.01 - 4.34 -1.22
NSRGF
Nestle SA
1.11
1.12%
100.36 26.86 18.76 3.13 7.10 3.81 21.70
NSRGY
Nestle SA ADR
-0.47
0.47%
100.36 26.82 18.66 3.18 7.07 3.81 21.70
DANOY
Danone PK
-0.08
0.58%
13.77 24.23 17.64 1.88 2.57 1.88 11.70
GPDNF
Danone S.A
-
-%
69.76 20.30 14.75 1.65 2.24 1.76 10.92

Profile*

Avenir Wellness Solutions Inc.

Avenir Wellness Solutions, Inc., together with its subsidiary, The Sera Labs, Inc., engages in the development of nutraceutical formulation and delivery technologies in dosage forms for wellness. The company offers its products in the health, wellness, and beauty sectors under the Seratopical, Seratopical Revolution SeraLabs, and Nutri-Strips brand names. It sells its products to direct-to-consumer through online website orders, including opt-in subscribe and save option, as well as online and in-store at national drug, mass retailers, grocery chains, convenience stores, and on Amazon.com. The company was formerly known as CURE Pharmaceutical Holding Corp. and changed its name to Avenir Wellness Solutions, Inc. in January 2023. Avenir Wellness Solutions, Inc. was incorporated in 2014 and is based in Sherman Oaks, California.

15233 Ventura Boulevard, Sherman Oaks, CA, United States, 91403

424 273 8675

Name Title Year Born
Mr. Robert Davidson Founder, Chief Scientist & Chairman of the Board 1967
Ms. Nancy Duitch CEO & Director 1955
Mr. Joel M. Bennett CPA CFO, Chief Accounting Officer, Secretary & Treasurer 1962
Ms. Patricia Hess Chief Operating Officer NA
Mr. Bhaumik Patel Director of New Technologies NA
Mr. John Cammarano Jr. Senior Vice President of Sales 1964
Dr. Rahul Dixit M.D. Chief Medical Officer & Member of Medical Advisory Board NA
Mr. Rick Petry Senior VP & Executive Creative Director NA
Mr. Joel M. Bennett CPA CFO, Chief Accounting Officer, Secretary, Treasurer & Interim CEO 1962

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…